89951-60-0 Usage
General Description
[1,1'-Biphenyl]-3-carboxaldehyde, 2-methyl- is a chemical compound with the formula C15H12O. It is a derivative of biphenyl, consisting of two benzene rings connected by a single carbon-carbon bond. The addition of a carboxaldehyde group to one of the rings and a methyl group to the other adds complexity to its structure. [1,1'-Biphenyl]-3-carboxaldehyde, 2-methyl- is used in the production of pharmaceuticals, agrochemicals, and various other organic synthesis processes. Its specific properties and potential applications may vary depending on the exact position and configuration of the methyl group and the functional groups bonded to the carbonyl carbon.
Check Digit Verification of cas no
The CAS Registry Mumber 89951-60-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,9,5 and 1 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 89951-60:
(7*8)+(6*9)+(5*9)+(4*5)+(3*1)+(2*6)+(1*0)=190
190 % 10 = 0
So 89951-60-0 is a valid CAS Registry Number.
89951-60-0Relevant articles and documents
Synthesis method of key intermediate of immune regulator
-
Paragraph 0032-0035, (2021/10/13)
The method comprises the following steps: dissolving compound 2 and compound 3, adding potassium carbonate, replacing nitrogen and adding S-Phos liter reaction. After completion of the cooling, filtration, concentration and organic phase were washed and d
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
-
Paragraph 0522-0523, (2018/07/15)
Disclosed are compounds of Formula (I′), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds inhibit PD-1/PD-L1 interaction and are useful in treating, preventing or ameliorating diseases or disorders such as cancer or infections.
HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
-
Page/Page column 61-62, (2017/06/12)
Disclosed are compounds of Formula (I), methods of using the compounds as immunomodulators, and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer or
